Interferon regulatory factor 7 participates in the M1-like microglial polarization switch

GLIA

Volumn 63, Issue 4, 2015, Pages 595-610

  Tanaka, Tatsuhide ^a   Murakami, Koichi ^a   Bando, Yoshio ^a   Yoshida, Shigetaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

IRF7; M1; M2; Microglia; Polarization

Indexed keywords

INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 4; NEUROTROPHIC FACTOR; SMALL INTERFERING RNA; STAT1 PROTEIN; LIPOPOLYSACCHARIDE; NERVE GROWTH FACTOR; STAT1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMYELINATION; FEMALE; GENE SILENCING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; M1 LIKE MICROGLIA; M2 LIKE MICROGLIA; MICROGLIA; MOUSE; NEURITE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD INJURY; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL POLARITY; CYTOLOGY; DEFICIENCY; DOWN REGULATION; DRUG EFFECTS; GENETICS; METABOLISM; NERVE CELL; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL POLARITY; CELLS, CULTURED; DOWN-REGULATION; INTERFERON REGULATORY FACTOR-7; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICROGLIA; NERVE GROWTH FACTORS; NEURITES; NEURONS; PHENOTYPE; PHOSPHORYLATION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR;

EID: 84922812185     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22770     Document Type: Article

References (54)

1. Ajmone-Cat MA, Mancini M, De Simone R, Cilli P, Minghetti L. 2013. Microglial polarization and plasticity: Evidence from organotypic hippocampal slice cultures. Glia 61:1698-1711.
2. Beutner C, Linnartz-Gerlach B, Schmidt SV, Beyer M, Mallmann MR, Staratschek-Jox A, Schultze JL, Neumann H. 2013. Unique transcriptome signature of mouse microglia. Glia 61:1429-1442.
3. Biber K, Owens T, Boddeke E. 2014. What is microglia neurotoxicity (not)? Glia 62:841-854.
4. Bouhlel MA, Derudas B, Rigamonti E, Dièvart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N, Staels B, Chinetti-Gbaguidi G. 2007. PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 6:137-143.
5. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, Fanek Z, Liu L, Chen Z, Rothstein JD, Ransohoff RM, Gygi SP, Antel JP, Weiner HL. 2014. Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat Neurosci 17:131-143.
6. Chhor V, Le Charpentier T, Lebon S, Oré MV, Celador IL, Josserand J, Degos V, Jacotot E, Hagberg H, Sävman K, Mallard C, Gressens P, Fleiss B. 2013. Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav Immun 32:70-85.
7. David S, Kroner A. 2011. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 12:388-399.
8. Durafourt BA, Moore CS, Zammit DA, Johnson TA, Zaguia F, Guiot MC, Bar-Or A, Antel JP. 2012. Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia 60:717-727.
9. Ellert-Miklaszewska A, Dabrowski M, Lipko M, Sliwa M, Maleszewska M, Kaminska B. 2013. Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia. Glia 61:1178-1190.
10. Fu R, Shen Q, Xu P, Luo JJ, Tang Y. 2014. Phagocytosis of microglia in the central nervous system diseases. Mol Neurobiol 49:1422-1434.
11. Fujita H, Tanaka J, Toku K, Tateishi N, Suzuki Y, Matsuda S, Sakanaka M, Maeda N. 1996. Effects of GM-CSF and ordinary supplements on the ramification of microglia in culture: A morphometrical study. Glia 18:269-281.
12. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330:841-845.
13. Hanisch UK, Kettenmann H. 2007. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10:1387-1394.
14. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777.
15. Horiuchi M, Wakayama K, Itoh A, Kawai K, Pleasure D, Ozato K, Itoh T. 2012. Interferon regulatory factor 8/interferon consensus sequence binding protein is a critical transcription factor for the physiological phenotype of microglia. J Neuroinflamm 9:227.
16. Hosmane S, Tegenge MA, Rajbhandari L, Uapinyoying P, Kumar NG, Thakor N, Venkatesan A. 2012. Toll/interleukin-1 receptor domain-containing adapter inducing interferon-β mediates microglial phagocytosis of degenerating axons. J Neurosci 32:7745-7757.
17. Hu X, Chen J, Wang L, Ivashkiv LB. 2007. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J Leukoc Biol 82:237-243.
18. Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, Gao Y, Chen J. 2012. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43:3063-3070.
19. Jenkins SJ, Ruckerl D, Cook PC, Jones LH, Finkelman FD, van Rooijen N, MacDonald AS, Allen JE. 2011. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332:1284-1288.
20. Khorooshi R, Owens T. 2010. Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system. J Immunol 185:1258-1264.
21. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. 2009. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29:13435-13444.
22. Kloss CU, Bohatschek M, Kreutzberg GW, Raivich G. 2001. Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture. Exp Neurol 168:32-46.
23. Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N, Hussell T, Feldmann M, Udalova IA. 2011. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol 12:231-238.
24. Liu YC, Zou XB, Chai YF, Yao YM. 2014. Macrophage polarization in inflammatory diseases. Int J Biol Sci 10:520-529.
25. Lucin KM, O'Brien CE, Bieri G, Czirr E, Mosher KI, Abbey RJ, Mastroeni DF, Rogers J, Spencer B, Masliah E, Wyss-Coray T. 2013. Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's disease. Neuron 79:873-886.
26. Lucin KM, Wyss-Coray T. 2009. Immune activation in brain aging and neurodegeneration: Too much or too little? Neuron 64:110-122.
27. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677-686.
28. Marié I, Durbin JE, Levy DE. 1998. Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7. EMBO J 17:6660-6669.
29. Masuda T, Tsuda M, Yoshinaga R, Tozaki-Saitoh H, Ozato K, Tamura T, Inoue K. 2012. IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype. Cell Rep 1:334-340.
30. Matsushima GK, Morell P. 2001. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107-116.
31. Melief J, Koning N, Schuurman KG, Van De Garde MD, Smolders J, Hoek RM, Van Eijk M, Hamann J, Huitinga I. 2012. Phenotyping primary human microglia: Tight regulation of LPS responsiveness. Glia 60:1506-1517.
32. Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, van Wijngaarden P, Wagers AJ, Williams A, Franklin RJ, ffrench-Constant C. 2013. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16:1211-1218.
33. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958-969.
34. Murakami K, Jiang YP, Tanaka T, Bando Y, Mitrovic B, Yoshida S. 2013. In vivo analysis of kallikrein-related peptidase 6 (KLK6) function in oligodendrocyte development and the expression of myelin proteins. Neuroscience 236:1-11.
35. Olah M, Amor S, Brouwer N, Vinet J, Eggen B, Biber K, Boddeke HW. 2012. Identification of a microglia phenotype supportive of remyelination. Glia 60:306-321.
36. Owens T, Khorooshi R, Wlodarczyk A, Asgari N. 2014. Interferons in the central nervous system: A few instruments play many tunes. Glia 62:339-355.
37. Perry VH, Nicoll JA, Holmes C. 2010. Microglia in neurodegenerative disease. Nat Rev Neurol 6:193-201.
38. Przanowski P, Dabrowski M, Ellert-Miklaszewska A, Kloss M, Mieczkowski J, Kaza B, Ronowicz A, Hu F, Piotrowski A, Kettenmann H, Komorowski J, Kaminska B. 2014. The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia. J Mol Med (Berl) 92:239-254.
39. Saijo K, Glass CK. 2011. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11:775-787.
40. Salem M, Mony JT, Løbner M, Khorooshi R, Owens T. 2011. Interferon regulatory factor-7 modulates experimental autoimmune encephalomyelitis in mice. J Neuroinflamm 8:181.
41. Sato M, Hata N, Asagiri M, Nakaya T, Taniguchi T, Tanaka N. 1998. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 441:106-110.
42. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, Miyake T, Matsushita K, Okazaki T, Saitoh T, Honma K, Matsuyama T, Yui K, Tsujimura T, Standley DM, Nakanishi K, Nakai K, Akira S. 2010. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 11:936-944.
43. Schmid CD, Melchior B, Masek K, Puntambekar SS, Danielson PE, Lo DD, Sutcliffe JG, Carson MJ. 2009. Differential gene expression in LPS/IFNγ activated microglia and macrophages: In vitro versus in vivo. J Neurochem 109:117-125.
44. Shimizu E, Kawahara K, Kajizono M, Sawada M, Nakayama H. 2008. IL-4-induced selective clearance of oligomeric β-amyloid peptide1-42 by rat primary type 2 microglia. J Immunol 181:6503-6513.
45. Sica A, Bronte V. 2007. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 117:1155-1166.
46. Sica A, Mantovani A. 2012. Macrophage plasticity and polarization: In vivo veritas. J Clin Invest 122:787-795.
47. Stein M, Keshav S, Harris N, Gordon S. 1992. Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologic macrophage activation. J Exp Med 176:287-292.
48. Takaoka A, Tamura T, Taniguchi T. 2008. Interferon regulatory factor family of transcription factors and regulation of oncogenesis. Cancer Sci 99:467-478.
49. Tanaka T, Murakami K, Bando Y, Yoshida S. 2013. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination. J Neurochem 127:259-270.
50. Tanaka T, Ueno M, Yamashita T. 2009. Engulfment of axon debris by microglia requires p38 MAPK activity. J Biol Chem 284:21626-21636.
51. Ueno M, Fujita Y, Tanaka T, Nakamura Y, Kikuta J, Ishii M, Yamashita T. 2013. Layer V cortical neurons require microglial support for survival during postnatal development. Nat Neurosci 16:543-551.
52. Wang G, Zhang J, Hu X, Zhang L, Mao L, Jiang X, Liou AK, Leak RK, Gao Y, Chen J. 2013. Microglia/macrophage polarization dynamics in white matter after traumatic brain injury. J Cereb Blood Flow Metab 33:1864-1874.
53. Wergeland S, Torkildsen Ø, Myhr KM, Mørk SJ, Bø L. 2012. The cuprizone model: Regional heterogeneity of pathology. APMIS 120:648-657.
54. Zhou X, Spittau B, Krieglstein K. 2012. TGFβ signalling plays an important role in IL4-induced alternative activation of microglia. J Neuroinflamm 9:210.